GeneDx Holdings Corp. (WGS) Operating cash flow 2019–2025
GeneDx Holdings Corp. (WGS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$33.3MFY2025 · since FY2019: -$18.7M → $33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $33.3M | +216.8% |
| FY2024 | -$28.5M | +84.2% |
| FY2023 | -$180.1M | +43.6% |
| FY2022 | -$319.2M | -67.6% |
| FY2021 | -$190.4M | -104.5% |
| FY2020 | -$93.1M | -397.3% |
| FY2019 | -$18.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice